Skip to Main content
Skip to Navigation
Toggle navigation
Sign in
Sign in
Sign in with ORCID
se connecter avec Fédération
Create account
Forgot your password?
Have you forgotten your login?
fr
en
Bienvenue sur la page d'accueil de la collection CRCL
Homepage
Folder
Browse by author
Browse latest submissions
Browse by period
Browse by doctype
Browse by teams
Homepage
Derniers dépôts
Boris Guyot, Sylvain Lefort, Thibault Voeltzel, Eve-Isabelle Pécheur, Véronique Maguer-Satta. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer. Frontiers in Cell and Developmental Biology, Frontiers media, 2022, 9, pp.787989. ⟨10.3389/fcell.2021.787989⟩. ⟨hal-03747851⟩
Eve-Isabelle Pécheur, Fabien Zoulim, Birke Bartosch. HCV Virology. Hepatitis C : Epidemiology, Prevention and Elimination, Springer, 2021, ⟨10.1007/978-3-030-64649-3_1⟩. ⟨hal-03747793⟩
Luiz W. Ribeiro, Mathé Pietri, Hector Ardila-Osorio, Anne Baudry, François Boudet-Devaud, et al.. Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling. Particle and Fibre Toxicology, BioMed Central, 2022, 19 (1), pp.48. ⟨10.1186/s12989-022-00490-x⟩. ⟨anses-03736622⟩
Manuarii Manuel. Étude des distorsions du répertoire immunitaire en tant que facteur pronostique de risque chez les patientes souffrant d’un cancer du sein métastatique en 1ère rechute : étude de la valeur pronostique de la lymphopénie et de la divpénie. Immunologie. Université Claude Bernard - Lyon I, 2012. Français. ⟨NNT : 2012LYO10029⟩. ⟨tel-03738082⟩
Adrien Bertrand. Implications oncogéniques des protéines SMAD2 & SMAD3 dans l’adénocarcinome canalaire pancréatique SMAD4-négatif. Cancer. Université de Lyon, 2021. Français. ⟨NNT : 2021LYSE1299⟩. ⟨tel-03735480⟩
Philippe Icard, Zherui Wu, Ludovic Fournel, Antoine Coquerel, Hubert Lincet, et al.. ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Letters, Elsevier, 2020, 471, pp.125 - 134. ⟨10.1016/j.canlet.2019.12.010⟩. ⟨hal-03488730⟩
Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, Hélène Blons, Jean-Philippe Merlio, et al.. Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer, Elsevier, 2020, 140, pp.19-26. ⟨10.1016/j.lungcan.2019.10.013⟩. ⟨hal-02483277⟩
William Mouton, Chloé Albert-Vega, Mathilde Boccard, François Bartolo, Guy Oriol, et al.. Towards standardization of immune functional assays. Clinical Immunology, Elsevier, 2020, 210, pp.108312. ⟨10.1016/j.clim.2019.108312⟩. ⟨hal-03489061⟩
Michaël Duruisseaux. Lorlatinib: a new treatment option for ROS1-positive lung cancer. Lancet Oncology, Elsevier, 2019, 20, pp.1622 - 1623. ⟨10.1016/S1470-2045(19)30716-8⟩. ⟨hal-03489050⟩
E. Gobbini, J. Charles, Ac. Toffart, Mt Leccia, D. Moro-Sibilot, et al.. Current opinions in immune checkpoint inhibitors rechallenge in solid cancers. Critical Reviews in Oncology/Hematology, Elsevier, 2019, 144, pp.102816 -. ⟨10.1016/j.critrevonc.2019.102816⟩. ⟨hal-03488926⟩
P. Corbaux, D. Maillet, A. Boespflug, M. Locatelli-Sanchez, M. Perier-Muzet, et al.. Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting. Eur J Cancer, 2019, 121, pp.192--201. ⟨10.1016/j.ejca.2019.08.027⟩. ⟨hal-02465794⟩
Marc Bonnin, Nadim Fares, Barbara Testoni, Yann Estornes, Kathrin Weber, et al.. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis. Journal of Hepatology, Elsevier, 2019, 71 (4), pp.763-772. ⟨10.1016/j.jhep.2019.05.031⟩. ⟨hal-02367101⟩
Laura Mondragón, Rana Mhaidly, Gian Marco de Donatis, Marie Tosolini, Pascal Dao, et al.. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism. Cancer Cell, Elsevier, 2019, 36 (3), pp.268-287.e10. ⟨10.1016/j.ccell.2019.07.008⟩. ⟨hal-02323021⟩
Pierre Sujobert, Gilles Salles. Actualités dans le lymphome folliculaire. La Presse Médicale, Elsevier Masson, 2019, 48, pp.850 - 858. ⟨10.1016/j.lpm.2019.07.024⟩. ⟨hal-03487823⟩
Clémentine Sarkozy, Gilles Salles. Actualités dans les lymphomes à petites cellules non folliculaires. La Presse Médicale, Elsevier Masson, 2019, 48, pp.859 - 870. ⟨10.1016/j.lpm.2019.07.025⟩. ⟨hal-03487817⟩
Nombre de documents
684
Nombre de notices
1 003
Répartition par type de documents
Evolution